Dr. Steven Fruchtman has been named chief executive officer and a member of the board of directors, Onconova Therapeutics, Inc. Dr. Fruchtman has served as president of Onconova since June 2018, and originally joined the company in January 2015 as chief medical officer. Previously, he held senior leadership positions in pharmaceutical and biotechnology companies and academia. Dr. Fruchtman replaces Dr. Ramesh Kumar, who will transition to an advisory role for the company.   “Steve is the...